State Street’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$74.1M Sell
2,276,512
-221,537
-9% -$7.27M ﹤0.01% 1544
2025
Q4
$79.3M Buy
2,498,049
+1,072,176
+75% +$32.2M ﹤0.01% 1484
2025
Q3
$33.5M Sell
1,425,873
-61,283
-4% -$1.05M ﹤0.01% 1954
2025
Q2
$16.9M Sell
1,487,156
-88,127
-6% -$837K ﹤0.01% 2282
2025
Q1
$10.5M Sell
1,575,283
-12,380
-0.8% -$115K ﹤0.01% 2502
2024
Q4
$17.5M Sell
1,587,663
-141,225
-8% -$1.73M ﹤0.01% 2296
2024
Q3
$21.2M Buy
1,728,888
+137,145
+9% +$1.94M ﹤0.01% 2172
2024
Q2
$21.5M Buy
1,591,743
+1,012,136
+175% +$13.7M ﹤0.01% 2131
2024
Q1
$7.82M Buy
579,607
+36,074
+7% +$219K ﹤0.01% 2718
2023
Q4
$2.86M Sell
543,533
-42,475
-7% -$182K ﹤0.01% 3184
2023
Q3
$2.31M Buy
586,008
+34,326
+6% +$226K ﹤0.01% 3267
2023
Q2
$5.86M Buy
551,682
+130,054
+31% +$1.38M ﹤0.01% 2922
2023
Q1
$3.51M Buy
421,628
+7,879
+2% +$71.1K ﹤0.01% 3120
2022
Q4
$3.82M Buy
413,749
+2,259
+0.5% +$23.5K ﹤0.01% 3159
2022
Q3
$5.28M Buy
411,490
+29,384
+8% +$468K ﹤0.01% 3033
2022
Q2
$5.05M Sell
382,106
-571,919
-60% -$8.69M ﹤0.01% 3098
2022
Q1
$20.1M Buy
954,025
+157,173
+20% +$3.15M ﹤0.01% 2398
2021
Q4
$19.1M Sell
796,852
-117,819
-13% -$2.81M ﹤0.01% 2503
2021
Q3
$23.3M Buy
914,671
+9,835
+1% +$274K ﹤0.01% 2374
2021
Q2
$30.5M Buy
904,836
+157,548
+21% +$5.57M ﹤0.01% 2214
2021
Q1
$29M Buy
747,288
+313,180
+72% +$17.8M ﹤0.01% 2120
2020
Q4
$26.9M Buy
434,108
+204,696
+89% +$9.38M ﹤0.01% 2049
2020
Q3
$7.68M Sell
229,412
-37,727
-14% -$1.08M ﹤0.01% 2581
2020
Q2
$6.37M Sell
267,139
-27,142
-9% -$644K ﹤0.01% 2642
2020
Q1
$6.74M Buy
294,281
+124,537
+73% +$3.08M ﹤0.01% 2483
2019
Q4
$4.81M Buy
169,744
+30,765
+22% +$774K ﹤0.01% 2868
2019
Q3
$2.99M Buy
+138,979
New +$3.88M ﹤0.01% 3061

Other funds holding STOK